Dr. Kirk Campbell is the C. Mahlon Kline Professor of Medicine and Chief of the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania Perelman School of Medicine. Prior to joining Penn, Dr. Campbell was a Professor of Medicine at Mount Sinai in New York, where he held a number of leadership roles including serving as the founding Director of the Mount Sinai Center for Kidney Disease Innovation, Nephrology Fellowship Director and Vice Chair of the Department of Medicine.
In addition to treating patients with kidney disease, Dr. Campbell leads a translational research program centered on developing novel therapeutic interventions for proteinuric kidney diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American Society for Clinical Investigation.
He is a Past-President of the New York Society of Nephrology and a member of the Board of Directors of the NephCure Foundation. Dr. Campbell is the current President of the National Kidney Foundation and Chairs its Scientific Advisory Board.
Dr. Kirk Campbell is the C. Mahlon Kline Professor of Medicine and Chief of the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania Perelman School of Medicine. Prior to joining Penn, Dr. Campbell was a Professor of Medicine at Mount Sinai in New York where he held a number of leadership roles including serving as the founding Director of the Mount Sinai Center for Kidney Disease Innovation, Nephrology Fellowship Director and Vice Chair of the Department of Medicine.
In addition to treating patients with kidney disease, Dr. Campbell leads a translational research program
centered on developing novel therapeutic interventions for proteinuric kidney diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American
Society for Clinical Investigation.
He is a Past-President of the New York Society of Nephrology and a member of the Board of Directors of the NephCure Foundation. Dr. Campbell is the current President of the National Kidney Foundation and Chairs its Scientific Advisory Board.
Kirk Campbell, MD
SCIENTIFIC FOUNDER & CHAIRMAN
SCIENTIFIC FOUNDER & CHAIRMAN
Kirk Campbell, MD
Attending Physician, Professor and Chief of the Renal Division at the Univ. of Pennsylvania
Dr. Kirk Campbell is the C. Mahlon Kline Professor of Medicine and Chief of the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania Perelman School of Medicine. Prior to joining Penn, Dr. Campbell was a Professor of Medicine at Mount Sinai in New York, where he held a number of leadership roles including serving as the founding Director of the Mount Sinai Center for Kidney Disease Innovation, Nephrology Fellowship Director and Vice Chair of the Department of Medicine.
In addition to treating patients with kidney disease, Dr. Campbell leads a translational research program centered on developing novel therapeutic interventions for proteinuric kidney diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American Society for Clinical Investigation.
He is a Past-President of the New York Society of Nephrology and a member of the Board of Directors of the NephCure Foundation. Dr. Campbell is the current President of the National Kidney Foundation and Chairs its Scientific Advisory Board.
Attending Physician, Professor and Chief of the Renal Division at the University of Pennsylvania
Dr. Kirk Campbell is the C. Mahlon Kline Professor of Medicine and Chief of the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania Perelman School of Medicine. Prior to joining Penn, Dr. Campbell was a Professor of Medicine at Mount Sinai in New York where he held a number of leadership roles including serving as the founding Director of the Mount Sinai Center for Kidney Disease Innovation, Nephrology Fellowship Director and Vice Chair of the Department of Medicine.
In addition to treating patients with kidney disease, Dr. Campbell leads a translational research program
centered on developing novel therapeutic interventions for proteinuric kidney diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American
Society for Clinical Investigation.
He is a Past-President of the New York Society of Nephrology and a member of the Board of Directors of the NephCure Foundation. Dr. Campbell is the current President of the National Kidney Foundation and Chairs its Scientific Advisory Board.